Global Parenteral Formula Market is valued approximately at USD 7.11 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.96% over the forecast period 2024-2032. Parenteral nutrition often referred to as parenteral formula or parenteral feeding, is a method of feeding a person intravenously when they are unable to consume food through the gastrointestinal tract. It involves delivering a specialized liquid formula containing nutrients directly into the bloodstream via a vein to provide essential nutrients such as carbohydrates, proteins, fats, vitamins, minerals, and electrolytes. These Parenteral formulas are carefully balanced to meet the individual patient's nutritional needs based on factors such as age, weight, medical condition, and metabolic requirements.
The Parenteral Formula Market is driven by the increasing prevalence of chronic disorders such as cancer, kidney failure, and diabetes. These conditions often necessitate parenteral nutrition, which provides essential nutrients directly into the bloodstream for patients unable to consume food orally. The aging global population significantly contributes to the market's growth, as older adults frequently encounter difficulties in medication intake due to frailty, dysphagia, or other age-related complications. Parenteral formulas thus play a crucial role in managing nutritional deficiencies among senior citizens. Furthermore, rising cases of malnutrition across economically deprived regions are expected to push the demand for parenteral nutrition solutions. Additionally, there is an increasing demand for whole protein and general formulas for both children and adults to help maintain overall health, presenting significant growth opportunities in the market. However, high cost of parenteral nutrition and regulatory constraints is going to impede the overall demand for the market during the forecast period 2024-2032.
The key regions considered for the global Parenteral Formula market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in 2023, driven by advanced healthcare infrastructure and high awareness regarding parenteral nutrition. North America benefits from a high level of awareness among healthcare professionals and the general population regarding the importance and benefits of parenteral nutrition. There is a robust understanding of when and how to utilize parenteral formulas, particularly in cases where patients cannot consume food orally or via tube feeding due to severe illness, surgery recovery, or digestive disorders. Furthermore, the market in Asia Pacific is anticipated to develop at the fastest rate over the forecast period 2024-2032.
Major market players included in this report are:
Baxter International Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Hospira, Inc
Sichuan Kelun Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Grifols, S.A.
Aculife Healthcare Private Limited
Vifor Pharma Group
Terumo Corporation
Nutricia
The detailed segments and sub-segment of the market are explained below:
By Type of Nutrient:
Carbohydrates
Amino Acids
Lipids
Electrolytes
Vitamins and Minerals
Specialty Formulas
By Indications:
Neurological Diseases
GI Disorders
Malnutrition
Alzheimer's
Cancer Care
Chronic Kidney Diseases
Dysphagia
Others
By Sale Channels:
Store-based
Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
